Monte Rosa Therapeutics Inc (GLUE)

Other Income/Expenses (Net)

$5.94M

Quarterly · Period ending: · USD

GLUE logo

GLUE Other Income/Expenses (Net)

Latest reported$5.94M
GLUE Quarterly Other Income/Expenses (Net) (-$9.00K → $5.94M)
High-resolution chart · PNG

GLUE other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Monte Rosa Therapeutics Inc Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
5,941,000
5,583,000
3,639,000
2,717,000
4,458,000
3,671,000
2,597,000
2,739,000
2,584,000
3,062,000
1,589,000
2,255,000
2,233,000
2,221,000
1,707,000
1,044,000
762,000
370,000
-53,000
31,000
-282,000
-772,000
-7,720,000
-172,000
32,000
-9,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.